Seralutinib (GB002) is an inhaled PDGFRalpha and PDGFRbeta inhibitor. Seralutinib also targets to CSF1R and c-KIT with IC50s of 8 nM and 14 nM, respectively. Seralutinib (GB002) is used in the study for pulmonary arterial hypertension[1][2].
Molecular Weight:
469.53
Purity:
99.94
CAS Number:
[1619931-27-9]
Formula:
C27H27N5O3
Target:
c-Fms,c-Kit,PDGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
